Catalyst Wire Dossier Catalyst Wire Dossier

Durogesic

fentanyl transdermal patch · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Durogesic, covering 2011-05-18 to 2011-05-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy [Phase 3]

See pricing